Current Management of In-Stent Restenosis

Despite the advent of the drug-eluting stents (DES) and improved stent design, in-stent restenosis (ISR) remains a challenging problem. The currently available options for treatment of ISR include angioplasty alone, repeat stenting with DES or drug-coated balloons. Several recent studies have compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Her, Ae-Young, Shin, Eun-Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940640/
https://www.ncbi.nlm.nih.gov/pubmed/29737639
http://dx.doi.org/10.4070/kcj.2018.0103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940640/
https://www.ncbi.nlm.nih.gov/pubmed/29737639
http://dx.doi.org/10.4070/kcj.2018.0103

Ejemplares similares